Related references
Note: Only part of the references are listed.Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington's disease via suppressing MAPKs and NF-κB pathways in the striatum
Xiong Yang et al.
ACTA PHARMACOLOGICA SINICA (2021)
C60 Fullerene Reduces 3-Nitropropionic Acid-Induced Oxidative Stress Disorders and Mitochondrial Dysfunction in Rats by Modulation of p53, Bcl-2 and Nrf2 Targeted Proteins
Olga O. Gonchar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Telmisartan Protects Against Aluminum-Induced Alzheimer-like Pathological Changes in Rats
Mona Khalifa et al.
NEUROTOXICITY RESEARCH (2020)
Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model
Noha H. Sayed et al.
NEUROTHERAPEUTICS (2020)
The Renin-Angiotensin System in Huntington's Disease: Villain or Hero?
Thatiane C. G. Machado et al.
PROTEIN AND PEPTIDE LETTERS (2020)
Dapagliflozin improves behavioral dysfunction of Huntington's disease in rats via inhibiting apoptosis-related glycolysis
Ayman E. El-Sahar et al.
LIFE SCIENCES (2020)
The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury
Yanping Ding et al.
FRONTIERS IN NEUROLOGY (2020)
Thymoquinone loaded solid lipid nanoparticles counteracts 3-Nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington's disease
Surekha Ramachandran et al.
METABOLIC BRAIN DISEASE (2018)
Telmisartan Ameliorates Astroglial and Dopaminergic Functions in a Mouse Model of Chronic Parkinsonism
Sathiya Sekar et al.
NEUROTOXICITY RESEARCH (2018)
Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: A pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-κB signalling pathway modulation
Eman M. Elbaz et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease
Hanan El-Abhar et al.
PLOS ONE (2018)
Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways
Wen-Fang Chen et al.
PHYTOMEDICINE (2017)
Schisandra chinensis Stem Ameliorates 3-Nitropropionic Acid-Induced Striatal Toxicity via Activation of the Nrf2 Pathway and Inhibition of the MAPKs and NF-κB Pathways
Eun-Jeong Kim et al.
FRONTIERS IN PHARMACOLOGY (2017)
Angiotensins and Huntington's Disease: A Study on Immortalized Progenitor Striatal Cell Lines
Walmor C. De Mello et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia
X. Fan et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats
Lamiaa A. Ahmed et al.
MOLECULAR NEUROBIOLOGY (2016)
Angiotensin-(1-7) is Reduced and Inversely Correlates with Tau Hyperphosphorylation in Animal Models of Alzheimer's Disease
Teng Jiang et al.
MOLECULAR NEUROBIOLOGY (2016)
Apoptosis and Oxidative Stress in Neurodegenerative Diseases
Elena Radi et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Huntington disease: natural history, biomarkers and prospects for therapeutics
Christopher A. Ross et al.
NATURE REVIEWS NEUROLOGY (2014)
Telmisartan ameliorates glutamate-induced neurotoxicity: Roles of AT1 receptor blockade and PPARγ activation
Juan Wang et al.
NEUROPHARMACOLOGY (2014)
Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: Mitochondrial dysfunction and neurodegeneration
Ashwini Hariharan et al.
NEUROTOXICOLOGY (2014)
Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease
Jing Jin et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property
Birdavinder Singh et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2013)
Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders
Juan M. Saavedra
CLINICAL SCIENCE (2012)
Peroxisome Proliferator-Activated Receptor-γ Activation With Angiotensin II Type 1 Receptor Blockade Is Pivotal for the Prevention of Blood-Brain Barrier Impairment and Cognitive Decline in Type 2 Diabetic Mice
Li-Juan Min et al.
HYPERTENSION (2012)
Candesartan, an Angiotensin II AT1-Receptor Blocker and PPAR-γ Agonist, Reduces Lesion Volume and Improves Motor and Memory Function After Traumatic Brain Injury in Mice
Sonia Villapol et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease
Rupinder K. Sodhi et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Huntington's disease: a clinical review
Raymund A. C. Roos
ORPHANET JOURNAL OF RARE DISEASES (2010)
A Possible Neuroprotective Action of a Vinylic Telluride against Mn-Induced Neurotoxicity
Daiana S. Avila et al.
TOXICOLOGICAL SCIENCES (2010)
Animal models of Huntington's disease
Shilpa Ramaswamy et al.
ILAR JOURNAL (2007)
Peroxisome proliferator-activated receptor γ is expressed in hippocampal neurons and its activation prevents β-amyloid neurodegeneration:: role of Wnt signaling
NC Inestrosa et al.
EXPERIMENTAL CELL RESEARCH (2005)
Glycogen synthase kinase-3β-mediated tau phosphorylation in cultured cell lines
CWC Lee et al.
NEUROREPORT (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
